[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Site Facilities::
Contact us::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Copyright Policies




Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

:: Volume 9, Issue 1 (Winter 2020) ::
Shefaye Khatam 2020, 9(1): 6-13 Back to browse issues page
Incidence of Ischemic and Thrombotic Events Following Nontraumatic Intracerebral and Subarachnoid Hemorrhages
Mehdi Maghbooli * , Reza Ahmadi , Ghazaleh Bahrami
Department of Neurology, Vali-e-Asr Hospital, University of Medical Sciences Zanjan, Zanjan, Iran , m.maghbooli@zums.ac.ir
Abstract:   (2250 Views)
Introduction: Thromboischemic events contribute substantially to morbidity and mortality of intracerebral hemorrhage and subarachnoid hemorrhage. Therefore, we aimed to evaluate the incidence of neurologic and systemic thromboischemic events in patients with acute non-traumatic intracerebral hemorrhage and subarachnoid hemorrhage during the first 6 months after hemorrhage. Materials and Methods: In this randomized-cohort study, we enrolled 203 patients with acute non-traumatic intracerebral hemorrhage or subarachnoid hemorrhage admitted in the neurology ward of Zanjan Vali-e-Asr Hospital between January 2016 and September 2016. We recorded the risk factors (hypertension, diabetes mellitus, atrial fibrillation, Smoking), initial neurological indices (Glasgow coma scale, ICH score, Hunt and Hess grading), and bleeding size in these patients. Patients were then evaluated 1 week, 1 month, 3 months, and 6 months after intracerebral hemorrhage and subarachnoid hemorrhage for the incidence of deep vein thrombosis, pulmonary embolism, ischemic heart disease, and ischemic stroke. Results: 165 patients had intracerebral hemorrhage and 38 patients had subarachnoid hemorrhage. The cumulative incidence of thromboischemic events in an unselected intracerebral hemorrhage and subarachnoid hemorrhage population was 31%. The overall incidence rates of deep vein thrombosis, pulmonary embolism, ischemic heart disease, and ischemic stroke after 6 months of intracerebral hemorrhage and subarachnoid hemorrhage onset were 10.9%, 5%, 10%, and 7.4%, respectively. The mean time to the events was 145.5 ± 5.5 days. Conclusion: Age, smoking, hypertension, diabetes mellitus, and atrial fibrillation were the significant independent risk factors for thromboischemic events. Age, higher ICH score, Hunt & Hess grade, and hemorrhage size >30cc have shown significant correlations with the development of deep vein thrombosis.
Keywords: Cerebral Hemorrhage, Subarachnoid Hemorrhage, Thrombosis
Full-Text [PDF 1505 kb]   (819 Downloads)    
Type of Study: Research --- Open Access, CC-BY-NC | Subject: Neurology
1. Steiner T, Salman RA-S, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. International journal of stroke. 2014; 9(7): 840-55. [DOI:10.1111/ijs.12309]
2. Majeed A, Kim Y-K, Roberts RS, Holmström M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010; 41(12): 2860-6. [DOI:10.1161/STROKEAHA.110.593087]
3. Goldstein JN, Fazen LE, Wendell L, Chang Y, Rost NS, Snider R, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocritical care. 2009; 10(1): 28. [DOI:10.1007/s12028-008-9134-3]
4. Gorelick PB, Hier DB, Caplan LR, Langenberg P. Headache in acute cerebrovascular disease. Neurology. 1986; 36(11): 1445. [DOI:10.1212/WNL.36.11.1445]
5. Zissimopoulos A, Vogiatzaki T, Babatsikou F, Velissaratou M, Baloka L, Karathanos E, et al. The role of copeptin in patients with subarachnoid haemorrage. Hellenic journal of nuclear medicine. 2015; 18: 150.
6. Group ISTC. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. The Lancet. 1997; 349(9065): 1569-81. [DOI:10.1016/S0140-6736(97)04011-7]
7. Goba I, Turovska B, Belyakov S, Liepinsh E. Synthesis of Novel Unsymmetrically Substituted 1, 4-Dihydroisonicotinic Acid and its Derivatives. Chemistry of Heterocyclic Compounds. 2013; 49(5): 726-35. [DOI:10.1007/s10593-013-1304-3]
8. McConnell ED, Wei HS, Reitz KM, Kang H, Takano T, Vates GE, et al. Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2016; 36(9): 1537-52. [DOI:10.1177/0271678X15608389]
9. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. Journal of the neurological sciences. 2008; 272(1-2): 83-6. [DOI:10.1016/j.jns.2008.04.032]
10. Lee H-C, Chang K-C, Huang Y-C, Hung J-W, Chiu H-HE, Chen J-J, et al. Readmission, mortality, and first-year medical costs after stroke. Journal of the Chinese Medical Association. 2013; 76(12): 703-14. [DOI:10.1016/j.jcma.2013.08.003]
11. Liang CW, Su K, Liu JJ, Dogan A, Hinson HE. Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage. Journal of neurosurgery. 2015; 123(4): 891-6. [DOI:10.3171/2014.12.JNS141288]
12. Christensen MC, Dawson J, Vincent C. Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Adv Ther. 2008; 25(9): 831-41. [DOI:10.1007/s12325-008-0092-0]
13. Caplan LR. Intracerebral haemorrhage. The Lancet. 1992; 339(8794): 656-8. [DOI:10.1016/0140-6736(92)90804-C]
14. An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. Journal of stroke. 2017; 19(1): 3. [DOI:10.5853/jos.2016.00864]
15. Chen C-C, Lee T-H, Chung C-Y, Chang W-H, Hong J-P, Huang L-T, et al. Symptomatic pulmonary embolism among stroke patients in Taiwan: a retrospective cohort study. Topics in stroke rehabilitation. 2012; 19(5): 361-8. [DOI:10.1310/tsr1905-361]
16. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest. 2001; 119(1): 132S-75S. [DOI:10.1378/chest.119.1_suppl.132S]
17. Weill‐Engerer S, Meaume S, Lahlou A, Piette F, Saint‐Jean O, Sachet A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case‐control multicenter study. Journal of the American Geriatrics Society. 2004; 52(8): 1299-304. [DOI:10.1111/j.1532-5415.2004.52359.x]
18. Graipe A, Binsell‐Gerdin E, Söderström L, Mooe T. Incidence, Time Trends, and Predictors of Intracranial Hemorrhage During Long‐Term Follow‐up After Acute Myocardial Infarction. Journal of the American Heart Association. 2015; 4(12): e002290. [DOI:10.1161/JAHA.115.002290]
19. Berge E, Abdelnoor M, Nakstad P, Sandset P, Group HS. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. The Lancet. 2000; 355(9211): 1205-10. [DOI:10.1016/S0140-6736(00)02085-7]
20. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circulation research. 2016; 118(9): 1340-7. [DOI:10.1161/CIRCRESAHA.115.306841]
21. Khan MT, Ikram A, Saeed O, Afridi T, Sila CA, Smith MS, et al. Deep vein thrombosis in acute stroke-a systemic review of the literature. Cureus. 2017; 9(12). [DOI:10.7759/cureus.1982]
22. Kelly J, Rudd A, Lewis R, Hunt B. Venous thromboembolism after acute stroke. Stroke. 2001; 32(1): 262-7. [DOI:10.1161/01.STR.32.1.262]
23. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. The Lancet Neurology. 2012; 11(1): 101-18. [DOI:10.1016/S1474-4422(11)70264-2]
24. Kamins J, Nguyen P. Neurology Electives Catalog.
25. Arima H, Huang Y, Wang JG, Heeley E, Delcourt C, Parsons M, et al. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke. 2012; 43(8): 2236-8. [DOI:10.1161/STROKEAHA.112.651422]
26. Danese A, Cappellari M, Pancheri E, Mugnai G, Micheletti N, Tomelleri G, et al. The dispersion of myocardial repolarization in ischemic stroke and intracranial hemorrhage. Journal of electrocardiology. 2018; 51(4): 691-5. [DOI:10.1016/j.jelectrocard.2018.05.007]

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

maghbooli M, ahmadi R, bahrami G. Incidence of Ischemic and Thrombotic Events Following Nontraumatic Intracerebral and Subarachnoid Hemorrhages. Shefaye Khatam 2020; 9 (1) :6-13
URL: http://shefayekhatam.ir/article-1-2028-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 9, Issue 1 (Winter 2020) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 45 queries by YEKTAWEB 4652